Navignostics featured at AACR 2024

Share this article:

Zurich, Switzerland

Navignostics was present in San Diego, CA, early April for the American Association for Cancer Research’s Annual Meeting. This even represents the perfect place to learn about the latest advances in cancer science and medicine directly from the best minds in cancer research from institutions all over the world.

Navignostics’ CEO Jana Fischer took the opportunity to present the latest update on how the company is applying multiplexed tissue imaging to navigate treatment for individual cancer patients.

The replay of her talk is now available online:

Explore our services

Each tumor is unique, which is why each cancer patient needs a unique treatment plan. Navignostics helps clinicians identify the optimal therapy from a single tumor tissue section.

The success of clinical trials depends on selecting the right patient group, and Navignostics helps researchers recognize the patients that can benefit the most from their treatment approach.